Abciximab as a bridging strategy to overcome morphine–prasugrel interaction in STEMI patients

OBJECTIVE: The present study investigated whether the glycoprotein (GP)IIb/IIIa receptor blocker abciximab might be a successful bridging strategy to achieve adequate levels of platelet inhibition rapidly in cases where prasugrel is used in morphine‐pretreated ST‐elevation myocardial infarction (STE...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Br J Clin Pharmacol
मुख्य लेखकों: Siller‐Matula, Jolanta M., Specht, Simon, Kubica, Jacek, Alexopoulos, Dimitrios, De Caterina, Raffaele, Hobl, Eva‐Luise, Jilma, Bernd, Christ, Günter, Lang, Irene M.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2016
विषय:
Drug Interactions
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5061801/
https://ncbi.nlm.nih.gov/pubmed/27366874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13053
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन